{"name":"Baxter International","slug":"baxter","ticker":"BAX","exchange":"NYSE","domain":"baxter.com","description":"Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.","hq":"Deerfield, IL","founded":0,"employees":"37500","ceo":"Jose (Joe) Almeida","sector":"Medical Devices / Hospital Products","stockPrice":17.3,"stockChange":0.68,"stockChangePercent":4.09,"marketCap":"$8.9B","metrics":{"revenue":11244000000,"revenueGrowth":8,"grossMargin":35.7,"rdSpend":518000000,"netIncome":-957000000,"cash":1966000000,"dividendYield":2.17,"peRatio":8.5,"fiscalYear":"FY2025"},"revenueBreakdown":[{"name":"Cytoxan (Lyophilized)","genericName":"cyclophosphamide","slug":"cyclophosphamide","revenue":1000000000,"yoyGrowth":0,"percentOfTotal":52.6},{"name":"Wydase","genericName":"HYALURONIDASE","slug":"hyaluronidase","revenue":900000000,"yoyGrowth":0,"percentOfTotal":47.4}],"timeline":[{"date":"1950-01-01","label":"Wydase first approved","drug":"Wydase","drugSlug":"hyaluronidase","type":"approval","sentiment":"positive"},{"date":"1951-01-01","label":"Vialin first approved","drug":"Vialin","drugSlug":"mephentermine","type":"approval","sentiment":"positive"},{"date":"1959-01-01","label":"Cytoxan (Lyophilized) first approved","drug":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","type":"approval","sentiment":"positive"},{"date":"1959-01-01","label":"Cytoxan (Lyophilized) first approved","drug":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","type":"approval","sentiment":"positive"},{"date":"1963-01-01","label":"Metro I.V. In Plastic Container first approved","drug":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","type":"approval","sentiment":"positive"},{"date":"1964-01-01","label":"Mannitol first approved","drug":"Mannitol","drugSlug":"mannitol-20","type":"approval","sentiment":"positive"},{"date":"1964-01-01","label":"Aridol Kit first approved","drug":"Aridol Kit","drugSlug":"mannitol","type":"approval","sentiment":"positive"},{"date":"1964-01-01","label":"Pralidoxime Chloride (Autoinjector) first approved","drug":"Pralidoxime Chloride (Autoinjector)","drugSlug":"pralidoxime","type":"approval","sentiment":"positive"},{"date":"1965-01-01","label":"Plegisol In Plastic Container first approved","drug":"Plegisol In Plastic Container","drugSlug":"sodium-chloride-14-6","type":"approval","sentiment":"positive"},{"date":"1972-01-01","label":"Efrane first approved","drug":"Efrane","drugSlug":"enflurane","type":"approval","sentiment":"positive"},{"date":"1976-01-01","label":"Aminoacetic Acid 1.5% In Plastic Container first approved","drug":"Aminoacetic Acid 1.5% In Plastic Container","drugSlug":"glycine","type":"approval","sentiment":"positive"},{"date":"1979-01-01","label":"Cromosan first approved","drug":"Cromosan","drugSlug":"magnesium-acetate","type":"approval","sentiment":"positive"},{"date":"1979-01-01","label":"Forane first approved","drug":"Forane","drugSlug":"isoflurane","type":"approval","sentiment":"positive"},{"date":"1982-01-01","label":"Prepopik first approved","drug":"Prepopik","drugSlug":"magnesium-oxide","type":"approval","sentiment":"positive"},{"date":"1982-01-01","label":"Renacidin first approved","drug":"Renacidin","drugSlug":"citric-acid","type":"approval","sentiment":"positive"},{"date":"1988-01-01","label":"Ifex first approved","drug":"Ifex","drugSlug":"ifosfamide","type":"approval","sentiment":"positive"},{"date":"1988-01-01","label":"Mesnex first approved","drug":"Mesnex","drugSlug":"mesna","type":"approval","sentiment":"positive"},{"date":"1992-01-01","label":"Suprane first approved","drug":"Suprane","drugSlug":"desflurane","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Maxipime first approved","drug":"Maxipime","drugSlug":"cefepime-hydrochloride","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Maxipime first approved","drug":"Maxipime","drugSlug":"cefepime","type":"approval","sentiment":"positive"},{"date":"2003-01-01","label":"Cubicin first approved","drug":"Cubicin","drugSlug":"daptomycin","type":"approval","sentiment":"positive"},{"date":"2008-01-01","label":"Treanda first approved","drug":"Treanda","drugSlug":"bendamustine","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-02-02","label":"Metro I.V. In Plastic Container patent expiry (Formulation)","drug":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","type":"patent_expiry","sentiment":"negative"},{"date":"2028-02-19","label":"Metro I.V. In Plastic Container patent expiry (Formulation)","drug":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","type":"patent_expiry","sentiment":"negative"},{"date":"2028-06-27","label":"Metro I.V. In Plastic Container patent expiry (Method of Use)","drug":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","type":"patent_expiry","sentiment":"negative"},{"date":"2028-09-04","label":"Cubicin patent expiry (Method of Use)","drug":"Cubicin","drugSlug":"daptomycin","type":"patent_expiry","sentiment":"negative"},{"date":"2030-11-23","label":"Cubicin patent expiry (Formulation)","drug":"Cubicin","drugSlug":"daptomycin","type":"patent_expiry","sentiment":"negative"},{"date":"2032-06-28","label":"Metro I.V. In Plastic Container patent expiry (Method of Use)","drug":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","type":"patent_expiry","sentiment":"negative"},{"date":"2032-06-28","label":"Metro I.V. In Plastic Container patent expiry (Method of Use)","drug":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","type":"patent_expiry","sentiment":"negative"},{"date":"2032-06-28","label":"Metro I.V. In Plastic Container patent expiry (Formulation)","drug":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","type":"patent_expiry","sentiment":"negative"},{"date":"2032-06-28","label":"Metro I.V. In Plastic Container patent expiry (Formulation)","drug":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","type":"patent_expiry","sentiment":"negative"},{"date":"2033-09-11","label":"Cubicin patent expiry (Formulation)","drug":"Cubicin","drugSlug":"daptomycin","type":"patent_expiry","sentiment":"negative"},{"date":"2033-09-11","label":"Cubicin patent expiry (Formulation)","drug":"Cubicin","drugSlug":"daptomycin","type":"patent_expiry","sentiment":"negative"},{"date":"2035-06-26","label":"Cytoxan (Lyophilized) patent expiry (Formulation)","drug":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","type":"patent_expiry","sentiment":"negative"},{"date":"2035-06-26","label":"Cytoxan (Lyophilized) patent expiry (Formulation)","drug":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","type":"patent_expiry","sentiment":"negative"},{"date":"2035-07-13","label":"Cytoxan (Lyophilized) patent expiry (Formulation)","drug":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","type":"patent_expiry","sentiment":"negative"},{"date":"2035-07-13","label":"Cytoxan (Lyophilized) patent expiry (Formulation)","drug":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","type":"patent_expiry","sentiment":"negative"},{"date":"2035-12-01","label":"Cytoxan (Lyophilized) patent expiry (Formulation)","drug":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","type":"patent_expiry","sentiment":"negative"},{"date":"2035-12-01","label":"Cytoxan (Lyophilized) patent expiry (Formulation)","drug":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","type":"patent_expiry","sentiment":"negative"},{"date":"2036-02-15","label":"Cytoxan (Lyophilized) patent expiry (Formulation)","drug":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","type":"patent_expiry","sentiment":"negative"},{"date":"2036-02-15","label":"Cytoxan (Lyophilized) patent expiry (Formulation)","drug":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","type":"patent_expiry","sentiment":"negative"},{"date":"2036-02-15","label":"Cytoxan (Lyophilized) patent expiry (Formulation)","drug":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","type":"patent_expiry","sentiment":"negative"},{"date":"2036-02-15","label":"Cytoxan (Lyophilized) patent expiry (Formulation)","drug":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","type":"patent_expiry","sentiment":"negative"},{"date":"2038-08-28","label":"Cubicin patent expiry (Method of Use)","drug":"Cubicin","drugSlug":"daptomycin","type":"patent_expiry","sentiment":"negative"},{"date":"2038-08-28","label":"Cubicin patent expiry (Formulation)","drug":"Cubicin","drugSlug":"daptomycin","type":"patent_expiry","sentiment":"negative"},{"date":"2039-01-16","label":"Metro I.V. In Plastic Container patent expiry (Formulation)","drug":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","type":"patent_expiry","sentiment":"negative"},{"date":"2039-10-04","label":"Metro I.V. In Plastic Container patent expiry (Formulation)","drug":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","type":"patent_expiry","sentiment":"negative"},{"date":"2028-06-01","label":"GAMMAGARD LIQUID patent cliff ($1.4B at risk)","drug":"GAMMAGARD LIQUID","type":"patent_expiry","sentiment":"negative"},{"date":"2030-06-01","label":"BAXTER HEMOGLOBIN patent cliff ($500M at risk)","drug":"BAXTER HEMOGLOBIN","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":1000000000,"percentOfTotal":52.6,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Cytoxan (Lyophilized)","genericName":"cyclophosphamide","slug":"cyclophosphamide","indication":"Acute lymphoid leukemia, disease","status":"marketed","revenue":1000000000},{"name":"Ifex","genericName":"IFOSFAMIDE","slug":"ifosfamide","indication":"Third-line chemotherapy for germ cell testicular cancer","status":"marketed"},{"name":"Cytoxan (Lyophilized)","genericName":"CYCLOPHOSPHAMIDE","slug":"chembl-chembl1200796","indication":"Acute lymphoid leukemia, disease","status":"marketed"},{"name":"Mesnex","genericName":"MESNA","slug":"mesna","indication":"Prevention of Chemotherapy-Induced Hemorrhagic Cystitis","status":"marketed"},{"name":"Treanda","genericName":"BENDAMUSTINE","slug":"bendamustine","indication":"Chronic lymphoid leukemia, disease","status":"marketed"}]},{"name":"Other","slug":"other","revenue":900000000,"percentOfTotal":47.4,"drugCount":8,"colorKey":"immunology","drugs":[{"name":"Wydase","genericName":"HYALURONIDASE","slug":"hyaluronidase","indication":"Subcutaneous Fluid Administration","status":"marketed","revenue":900000000},{"name":"Plegisol In Plastic Container","genericName":"Sodium Chloride","slug":"sodium-chloride-14-6","indication":"Other","status":"marketed"},{"name":"Aminoacetic Acid 1.5% In Plastic Container","genericName":"GLYCINE","slug":"glycine","indication":"Allergic rhinitis","status":"marketed"},{"name":"Cromosan","genericName":"MAGNESIUM ACETATE","slug":"magnesium-acetate","indication":"Other","status":"marketed"},{"name":"DESF","genericName":"DESF","slug":"desf","indication":"General anesthesia","status":"marketed"},{"name":"Pralidoxime Chloride (Autoinjector)","genericName":"PRALIDOXIME","slug":"pralidoxime","indication":"Cholinesterase Inhibitors Toxicity","status":"marketed"},{"name":"Prepopik","genericName":"MAGNESIUM OXIDE","slug":"magnesium-oxide","indication":"Acid Indigestion Relief","status":"marketed"},{"name":"TRAVERT 10% IN PLASTIC CONTAINER","genericName":"INVERT SUGAR","slug":"invert-sugar","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"neuroscience","drugs":[{"name":"Cubicin","genericName":"Daptomycin","slug":"daptomycin","indication":"Bacteremia caused by Staphylococcus aureus","status":"marketed"},{"name":"Maxipime","genericName":"Cefepime Hydrochloride","slug":"cefepime-hydrochloride","indication":"Bacterial infection due to Klebsiella pneumoniae","status":"marketed"},{"name":"Maxipime","genericName":"CEFEPIME","slug":"cefepime","indication":"Bacterial infection due to Klebsiella pneumoniae","status":"marketed"},{"name":"DAPT","genericName":"DAPT","slug":"dapt","indication":"Bacteremia caused by Staphylococcus aureus","status":"marketed"},{"name":"Metro I.V. In Plastic Container","genericName":"METRONIDAZOLE","slug":"metronidazole","indication":"Abdominal abscess","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"infectious","drugs":[{"name":"Suprane","genericName":"DESFLURANE","slug":"desflurane","indication":"General anesthesia","status":"marketed"},{"name":"Efrane","genericName":"ENFLURANE","slug":"enflurane","indication":"General anesthesia","status":"marketed"},{"name":"Forane","genericName":"ISOFLURANE","slug":"isoflurane","indication":"General anesthesia","status":"marketed"},{"name":"Renacidin","genericName":"CITRIC ACID","slug":"citric-acid","indication":"Calcium Phosphate Renal Calculi","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Mannitol","genericName":"Mannitol","slug":"mannitol-20","indication":"Benign intracranial hypertension","status":"marketed"},{"name":"Aridol Kit","genericName":"MANNITOL","slug":"mannitol","indication":"Benign intracranial hypertension","status":"marketed"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Vialin","genericName":"MEPHENTERMINE","slug":"mephentermine","indication":"Hypotension Secondary to Spinal Anesthesia","status":"marketed"}]}],"pipeline":[{"name":"Cytoxan (Lyophilized)","genericName":"cyclophosphamide","slug":"cyclophosphamide","phase":"marketed","mechanism":"Cyclophosphamide cross-links tumor cell DNA and interferes with malignant cell growth through active alkylating metabolites.","indications":["Acute lymphoid leukemia, disease","Acute monocytic leukemia","Acute myelogenous leukemia","Adenocarcinoma of the ovary","Burkitt's lymphoma"],"catalyst":""},{"name":"Wydase","genericName":"HYALURONIDASE","slug":"hyaluronidase","phase":"marketed","mechanism":"Hyaluronidase increases tissue permeability by breaking down hyaluronic acid, promoting the diffusion and absorption of injected fluids.","indications":["Subcutaneous Fluid Administration","Dispersion and Absorption of Injected Drugs","Subcutaneous Urography"],"catalyst":""},{"name":"Mannitol","genericName":"Mannitol","slug":"mannitol-20","phase":"marketed","mechanism":"Osmotic diuretic that elevates glomerular filtrate osmolarity to inhibit tubular water reabsorption.","indications":["Benign intracranial hypertension","Cerebral edema","Cystic fibrosis","Edema","Hemolysis Prevention"],"catalyst":""},{"name":"Cubicin","genericName":"Daptomycin","slug":"daptomycin","phase":"marketed","mechanism":"Daptomycin is an antibacterial drug with lipopeptide structure.","indications":["Bacteremia caused by Staphylococcus aureus","Complicated Skin and Skin Structure Enterococcus Faecalis Infection","Complicated Skin and Skin Structure Staphylococcus Aureus Infection","Complicated Skin and Skin Structure Streptococcus Agalactiae Infection","Complicated Skin and Skin Structure Streptococcus Pyogenes Infection"],"catalyst":""},{"name":"Maxipime","genericName":"Cefepime Hydrochloride","slug":"cefepime-hydrochloride","phase":"marketed","mechanism":"Cefepime is a cephalosporin antibacterial drug that inhibits bacterial cell wall synthesis.","indications":["Bacterial infection due to Klebsiella pneumoniae","Bacterial peritonitis","Bacterial pneumonia","Bacterial urinary infection","Complicated Bacteroides Peritonitis"],"catalyst":""},{"name":"Plegisol In Plastic Container","genericName":"Sodium Chloride","slug":"sodium-chloride-14-6","phase":"marketed","mechanism":"Provides isotonic saline irrigation with mechanical cleansing action for sterile irrigation of body cavities, tissues, wounds, and surgical equipment.","indications":[],"catalyst":""},{"name":"Aminoacetic Acid 1.5% In Plastic Container","genericName":"GLYCINE","slug":"glycine","phase":"marketed","mechanism":"Olfactory receptor 51E2","indications":["Allergic rhinitis","Common cold","Cough","Nasal congestion","Nasal discharge"],"catalyst":""},{"name":"Ifex","genericName":"IFOSFAMIDE","slug":"ifosfamide","phase":"marketed","mechanism":"Ifosfamide is activated by liver enzymes to form cytotoxic compounds that cause DNA crosslinks, leading to cell death.","indications":["Third-line chemotherapy for germ cell testicular cancer"],"catalyst":""},{"name":"Maxipime","genericName":"CEFEPIME","slug":"cefepime","phase":"marketed","mechanism":"Cefepime is a cephalosporin antibacterial drug.","indications":["Bacterial infection due to Klebsiella pneumoniae","Bacterial peritonitis","Bacterial pneumonia","Bacterial urinary infection","Complicated Bacteroides Peritonitis"],"catalyst":""},{"name":"Suprane","genericName":"DESFLURANE","slug":"desflurane","phase":"marketed","mechanism":"GABA-A receptor; anion channel","indications":["General anesthesia"],"catalyst":""},{"name":"Aridol Kit","genericName":"MANNITOL","slug":"mannitol","phase":"marketed","mechanism":"Mannitol works by drawing water into the bloodstream from surrounding tissues, increasing urine production and reducing fluid accumulation in the body.","indications":["Benign intracranial hypertension","Cerebral edema","Cystic fibrosis","Edema","Hemolysis Prevention"],"catalyst":""},{"name":"Cromosan","genericName":"MAGNESIUM ACETATE","slug":"magnesium-acetate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cytoxan (Lyophilized)","genericName":"CYCLOPHOSPHAMIDE","slug":"chembl-chembl1200796","phase":"marketed","mechanism":"Cytoxan works by interfering with the DNA replication process in rapidly dividing cancer cells.","indications":["Acute lymphoid leukemia, disease","Acute monocytic leukemia","Acute myelogenous leukemia","Adenocarcinoma of the ovary","Burkitt's lymphoma"],"catalyst":""},{"name":"DAPT","genericName":"DAPT","slug":"dapt","phase":"marketed","mechanism":"Dapt is a small molecule that works by interacting with specific biological targets, but the exact details of this interaction are unknown.","indications":["Bacteremia caused by Staphylococcus aureus","Complicated Skin and Skin Structure Enterococcus Faecalis Infection","Complicated Skin and Skin Structure Staphylococcus Aureus Infection","Complicated Skin and Skin Structure Streptococcus Agalactiae Infection","Complicated Skin and Skin Structure Streptococcus Pyogenes Infection"],"catalyst":""},{"name":"DESF","genericName":"DESF","slug":"desf","phase":"marketed","mechanism":"Desf works by interacting with a specific biological target to produce a therapeutic effect.","indications":["General anesthesia"],"catalyst":""},{"name":"Efrane","genericName":"ENFLURANE","slug":"enflurane","phase":"marketed","mechanism":"Glycine receptor subunit alpha-1","indications":["General anesthesia"],"catalyst":""},{"name":"Forane","genericName":"ISOFLURANE","slug":"isoflurane","phase":"marketed","mechanism":"5-hydroxytryptamine receptor 2B","indications":["General anesthesia"],"catalyst":""},{"name":"Mesnex","genericName":"MESNA","slug":"mesna","phase":"marketed","mechanism":"Mesnex works by binding to and neutralizing acrolein, a toxic byproduct of chemotherapy that causes hemorrhagic cystitis.","indications":["Prevention of Chemotherapy-Induced Hemorrhagic Cystitis","Testicular Germ Cell Tumor"],"catalyst":""},{"name":"Metro I.V. In Plastic Container","genericName":"METRONIDAZOLE","slug":"metronidazole","phase":"marketed","mechanism":"Small molecule","indications":["Abdominal abscess","Abscess of brain","Abscess of liver","Acute amebiasis","Amebic dysentery"],"catalyst":""},{"name":"Pralidoxime Chloride (Autoinjector)","genericName":"PRALIDOXIME","slug":"pralidoxime","phase":"marketed","mechanism":"Pralidoxime Chloride works by reactivating the enzyme acetylcholinesterase, which is inhibited by organophosphate poisoning.","indications":["Cholinesterase Inhibitors Toxicity","Organophosphate poisoning","Organophosphorous Overdose","Poisoning due to Nerve Agent"],"catalyst":""},{"name":"Prepopik","genericName":"MAGNESIUM OXIDE","slug":"magnesium-oxide","phase":"marketed","mechanism":"Small molecule","indications":["Acid Indigestion Relief","Upset Stomach Relief"],"catalyst":""},{"name":"Renacidin","genericName":"CITRIC ACID","slug":"citric-acid","phase":"marketed","mechanism":"Renacidin works by inhibiting the formation of calcium oxalate crystals in the urine, which can help prevent kidney stones.","indications":["Calcium Phosphate Renal Calculi","Headache disorder","Indigestion","Pain","Struvite Renal Calculi"],"catalyst":""},{"name":"TRAVERT 10% IN PLASTIC CONTAINER","genericName":"INVERT SUGAR","slug":"invert-sugar","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"Treanda","genericName":"BENDAMUSTINE","slug":"bendamustine","phase":"marketed","mechanism":"Treanda works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and grow.","indications":["Chronic lymphoid leukemia, disease","Diffuse large B-cell lymphoma refractory","Follicular non-Hodgkin's lymphoma","Indolent B-Cell Lymphoma","Treatment prior to tumor-specific T-cell infusion therapy"],"catalyst":""},{"name":"Vialin","genericName":"MEPHENTERMINE","slug":"mephentermine","phase":"marketed","mechanism":"Alpha-1A adrenergic receptor","indications":["Hypotension Secondary to Spinal Anesthesia","Low blood pressure","Prevention of Hypotension During Spinal Anesthesia"],"catalyst":""}],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Baxter International Reports Fourth-Quarter and Full-Year 2023 Results","summary":"Baxter International reported its fourth-quarter and full-year 2023 results, with revenue of $4.3 billion and adjusted earnings per share of $1.35.","drugName":"","sentiment":"neutral"},{"date":"2023-09-01","type":"deal","headline":"Baxter International Acquires Cheetah Medical","summary":"Baxter International acquired Cheetah Medical, a company that develops non-invasive hemodynamic monitoring systems.","drugName":"","sentiment":"positive"},{"date":"2022-11-14","type":"regulatory","headline":"FDA Approves Baxter International's PRISMAFLO Blood Plasma Infusion System","summary":"The FDA approved Baxter International's PRISMAFLO Blood Plasma Infusion System, a device that helps patients with bleeding disorders.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE1SM0trU00wM0MxNld6VmZ4VldkNU5WWEFacHRhSkgyejdKMUhVWUFNWkJISnAxSjg4ZDR1ZTVkeWRwQVFrMDJ6blpMWk43elNa?oc=5","date":"2026-04-07","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Baxter International Inc. (BAX) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Baxter International Inc. (BAX) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPUV9qUTdVblVsQ1VpUnVSQmFaanBEanYwS2JWMTJVd2xOS1YwanRKN1pMeXNjSWNTaDlGOVM2NmQ3ZDdTR3RVX2hLU3F2ZDRVUEM4NlhERWNodGxiaS1ZajQ2TmVsUmJGS1dEa21PcnFFREdLZTl1WVBxdWVDaVU2eEFJeUdmdzRSLXhtQTdXUUhJWmhmS1BWbExNZzFNU0RnWENOS3h5VnZzVERCS2E3VVg4Z25EcF8xTmhvWWpIaTJJWExPNy04OFRGbFpmLURHUkRDaldweEs?oc=5","date":"2026-03-24","type":"pipeline","source":"Reuters","summary":"EU regulator flags Baxter cancer drug shortage until early next year - Reuters","headline":"EU regulator flags Baxter cancer drug shortage until early next year","sentiment":"neutral"},{"date":"2026-03-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPQ01WSkp6Mk1tWExrbF9ocW5DYk1UVm5tbVZ2NzdObGV4UFdYTTVPWmo1YWR3LTQzd1JrNUNUcEM1aDhjbDdCcmd1dWJ0YU5jQnFOSVFMY3ZXLWZ2MGw1VVZRTlVEWGlyRE1ickllUzQwelNSNDM2bE5WMTlvZkItdE8wQWZfZUExTUFtTGhXQ2NvN09uRzZaYzlMcTRpVUQ0SnlmVFZlYzFXeE5NaXdnRGhjcGFHcjdOT0ZYQ2ZTSk43eU9wMFpyc1dRcXp3M3pRT24wejNXZGQweWxFVWVFenBLSENnNU0xNE80WkxXLVJCajN3RE83LWh0SGVjM3JVWmZUZ2NvSlg4Y1NoYVZudEZMTEdSWkhVRWkzVlB3?oc=5","date":"2026-02-26","type":"pipeline","source":"The Globe and Mail","summary":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jazz Pharmaceuticals (JAZZ) and Baxter International (BAX) - The Globe and Mail","headline":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jazz Pharmaceuticals (JAZZ) and Baxter International (BAX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNVWNvcnBYV0laMTlDc1JoR2xuYWZ2MmdLM2o2QzBOdy1fMmxTQ09RUEZTNkZFSXhkdlRXdHp5OXBYTlhJdHVjNjhqc2xhOHcxanpkaVNrUU9YNXJPZXc3UkoyQVlpdW9HRkpLTU9OTjJSRkJLdEdOeUdGTzdKTWFsUUU5NE5QZlNfS0lxVEdOdmJnZWdKbWV3d2JTWEw5c2Y5d19MSVpWVGplUGptLWc?oc=5","date":"2026-02-12","type":"earnings","source":"TipRanks","summary":"Baxter International Reports Mixed Q4 Results and Outlook - TipRanks","headline":"Baxter International Reports Mixed Q4 Results and Outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPZkxBeFZwb2I5alVXX2kwZXl2WGtZbHlPamMwdzFNbThZNmFrQjlIaGZ3YmJmbElDMG9kMUxpS1FCUTAyVS1LakxCamVENnQtd0V1VU1DeTJpcTkycjk1NEJWRTYxWk9RS0pHU0c0MWE2WHp0eGFHTUFBRmtCTkktOXFFWFZib29CWDNYMkE1SE9sSVBZWkZEbTNJc3prMzZyVUVyeF9GYjlkWFhpSWFjNFBn?oc=5","date":"2026-02-10","type":"earnings","source":"TradingView","summary":"Baxter to Post Q4 Earnings: What's in Store for the Stock? - TradingView","headline":"Baxter to Post Q4 Earnings: What's in Store for the Stock?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdUZiYk5ja0NnYlh4NUE5Y055UHBQQkFxbkFVTEZha0g2OFhEVDlROXZlUk9GRVhnX1NJT0gyNkdfM1VyVHBRYnNzWThtcUJIdGc4Q1JuQk0xSW9sQnd2OG5qZGRRQ1JRYmtYUU9IbE40QUZOTHVIQkJvT1NOMWJoa3VrTDZqSU5NR3FHUTF6RHNZc2RyODFyX1d6bXpKb0RvUThFTVg4Zm8?oc=5","date":"2026-01-20","type":"pipeline","source":"Seeking Alpha","summary":"Baxter International: Transition Year With No Immediate Catalysts (NYSE:BAX) - Seeking Alpha","headline":"Baxter International: Transition Year With No Immediate Catalysts (NYSE:BAX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBvRjRvWm5pU0pmcEJ4eFA3d3R5ZmNmWlQ1bVFaakFWUExOLU1Nc21GTWRoVmVEMVc5MllJLXNqYnRQTVVqQWx5cUZvVVQtTzZzOFpBX196X1h1TFZtaENvVHZkZVdmS3FrM3pDcTk0ZFAtQ3NTZWZUT2lqSnQ?oc=5","date":"2026-01-05","type":"pipeline","source":"Yahoo Finance","summary":"Artisan Mid Cap Value Fund’s Views on Baxter International (BAX) - Yahoo Finance","headline":"Artisan Mid Cap Value Fund’s Views on Baxter International (BAX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNeTBlY0d3YjVrd2c0SEY4LUZkbDZDOHhKR0ZaQWZIb3MzVHVpTi1ITGk1T3RVZThiWmQ5Q0JnblZGV2IyUUQ2RS0zR1lMM1o4R2JyQ1pTMFlkNmtBSG92dTBkZHpvVlE4SkNzdG5QN0VfbkoyemdNaHpRTXprWVVYdm9MQU5BS1I1alpBZmdNZER4VHRGTzlkTFNpaUlsU2c?oc=5","date":"2026-01-01","type":"pipeline","source":"TIKR.com","summary":"Who Owns Baxter International? Top Shareholders and Recent Insider Trades - TIKR.com","headline":"Who Owns Baxter International? Top Shareholders and Recent Insider Trades","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOXzFzQm05ajNkaTktZV9sMlBUb1MzZ2JPS2t5TGRPNGVWMFNZNDJYQWxUZUM0d1h1MnNpbk1wUkdrM3lzbk55RFZybXQ1NzZsVTRqUHQ0NFRYY1dJbDNteG9RZUJTSlZJQWlOQVV0cl9lVldoQTVaei1KSXlFaFFuWVphV0haWjNwZGdtTk1veTFQX3lFRjIxOGNIY1NWa196eXBxdXljMGloZE1xbUdYeHpxLTZkcXVxaHFvUjdaWFhrYW9OUHBZ?oc=5","date":"2025-11-12","type":"pipeline","source":"Investing.com","summary":"Baxter International executive Alok Sonig to resign effective December 1 - Investing.com","headline":"Baxter International executive Alok Sonig to resign effective December 1","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-20","type":"pipeline","source":"globenewswire.com","summary":"Important Notice to Long-Term Shareholders of Amylyx - globenewswire.com","headline":"Important Notice to Long-Term Shareholders of Amylyx","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQejZCWUswMkxlVF9DMDVrTG9iRU9nc0kzOWgyNWpZU3E1X0M4OUdjYXpKeUhUaWFOc2xobTUtdUVqa1EtTVB4ZThsVnNQT0RkTGV0eVM3Y01CWHpBU3p1bjFxUnJfUjdGRmx1MkhBUDBfWVZNUlhzUkVlQnY1VzhfWnNldWctQWx1b3dfdV96QXY0RXFGeGlHb1dhNnc3QzdfdmxnQ0IwOGpzM2g4NkFlRXV2V0d3aklYWHlETWl5dzlscUJyMl94MjUwbnQxZ0NpR2paTHVtalZhLXZ3SVNF?oc=5","date":"2025-08-01","type":"pipeline","source":"Reuters","summary":"Medical products maker Baxter cuts 2025 forecast; shares plunge to 19-year low - Reuters","headline":"Medical products maker Baxter cuts 2025 forecast; shares plunge to 19-year low","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9BRWpPQ3VOd2RBNHRmUDZETTJPOFVMR0NCSThBczhFOU1fd2RvbWJlWmJJLTFyVGF4M2RjekJwdUpKR0R6RmQ1YmlMejEybF91Q25FcFJwRGpVSXlBLUE?oc=5","date":"2025-06-02","type":"pipeline","source":"fortune.com","summary":"Baxter International (BAX): Company Profile, Stock Price, News, Rankings - fortune.com","headline":"Baxter International (BAX): Company Profile, Stock Price, News, Rankings","sentiment":"neutral"}],"patents":[{"drugName":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","patentNumber":"8877792","type":"Formulation","expiryDate":"2028-02-02","territory":"US","genericFilings":[]},{"drugName":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","patentNumber":"7893097","type":"Formulation","expiryDate":"2028-02-19","territory":"US","genericFilings":[]},{"drugName":"GAMMAGARD LIQUID","drugSlug":"immune-globulin-intravenous-(human)","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1400000000},{"drugName":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","patentNumber":"8658678","type":"Method of Use","expiryDate":"2028-06-27","territory":"US","genericFilings":[]},{"drugName":"Cubicin","drugSlug":"daptomycin","patentNumber":"8003673","type":"Method of Use","expiryDate":"2028-09-04","territory":"US","genericFilings":[]},{"drugName":"BAXTER HEMOGLOBIN","drugSlug":"human-hemoglobin","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":500000000},{"drugName":"Cubicin","drugSlug":"daptomycin","patentNumber":"9138456","type":"Formulation","expiryDate":"2030-11-23","territory":"US","genericFilings":[]},{"drugName":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","patentNumber":"9198858","type":"Method of Use","expiryDate":"2032-06-28","territory":"US","genericFilings":[]},{"drugName":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","patentNumber":"8946276","type":"Method of Use","expiryDate":"2032-06-28","territory":"US","genericFilings":[]},{"drugName":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","patentNumber":"10238634","type":"Formulation","expiryDate":"2032-06-28","territory":"US","genericFilings":[]},{"drugName":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","patentNumber":"10596155","type":"Formulation","expiryDate":"2032-06-28","territory":"US","genericFilings":[]},{"drugName":"Cubicin","drugSlug":"daptomycin","patentNumber":"10357535","type":"Formulation","expiryDate":"2033-09-11","territory":"US","genericFilings":[]},{"drugName":"Cubicin","drugSlug":"daptomycin","patentNumber":"9655946","type":"Formulation","expiryDate":"2033-09-11","territory":"US","genericFilings":[]},{"drugName":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","patentNumber":"9662342","type":"Formulation","expiryDate":"2035-06-26","territory":"US","annualRevenue":1000000000,"genericFilings":[]},{"drugName":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","patentNumber":"9662342","type":"Formulation","expiryDate":"2035-06-26","territory":"US","genericFilings":[]},{"drugName":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","patentNumber":"10849916","type":"Formulation","expiryDate":"2035-07-13","territory":"US","annualRevenue":1000000000,"genericFilings":[]},{"drugName":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","patentNumber":"10849916","type":"Formulation","expiryDate":"2035-07-13","territory":"US","genericFilings":[]},{"drugName":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","patentNumber":"11382923","type":"Formulation","expiryDate":"2035-12-01","territory":"US","annualRevenue":1000000000,"genericFilings":[]},{"drugName":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","patentNumber":"11382923","type":"Formulation","expiryDate":"2035-12-01","territory":"US","genericFilings":[]},{"drugName":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","patentNumber":"12329767","type":"Formulation","expiryDate":"2036-02-15","territory":"US","annualRevenue":1000000000,"genericFilings":[]},{"drugName":"Cytoxan (Lyophilized)","drugSlug":"cyclophosphamide","patentNumber":"10993952","type":"Formulation","expiryDate":"2036-02-15","territory":"US","annualRevenue":1000000000,"genericFilings":[]},{"drugName":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","patentNumber":"12329767","type":"Formulation","expiryDate":"2036-02-15","territory":"US","genericFilings":[]},{"drugName":"Cytoxan (Lyophilized)","drugSlug":"chembl-chembl1200796","patentNumber":"10993952","type":"Formulation","expiryDate":"2036-02-15","territory":"US","genericFilings":[]},{"drugName":"Cubicin","drugSlug":"daptomycin","patentNumber":"12053502","type":"Method of Use","expiryDate":"2038-08-28","territory":"US","genericFilings":[]},{"drugName":"Cubicin","drugSlug":"daptomycin","patentNumber":"11759497","type":"Formulation","expiryDate":"2038-08-28","territory":"US","genericFilings":[]},{"drugName":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","patentNumber":"12257236","type":"Formulation","expiryDate":"2039-01-16","territory":"US","genericFilings":[]},{"drugName":"Metro I.V. In Plastic Container","drugSlug":"metronidazole","patentNumber":"11541035","type":"Formulation","expiryDate":"2039-10-04","territory":"US","genericFilings":[]}],"drugCount":25,"phaseCounts":{"marketed":25},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Fresenius Medical Care","DaVita Inc.","Grifols S.A."],"therapeuticFocus":["Renal and Cardiovascular Health","Critical Care and Anesthesiology"],"financials":{"source":"sec_edgar","revenue":11244000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":11244000000,"period":"2025-12-31"},{"value":10636000000,"period":"2024-12-31"},{"value":10636000000,"period":"2024-12-31"},{"value":2753000000,"period":"2024-12-31"},{"value":2699000000,"period":"2024-09-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":518000000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-957000000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":20055000000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":17.3,"previousClose":16.62,"fiftyTwoWeekHigh":32.68,"fiftyTwoWeekLow":15.73,"fiftyTwoWeekRange":"15.73 - 32.68","fiftyDayAverage":18.99,"twoHundredDayAverage":21.88,"beta":0.62,"enterpriseValue":16337824768,"forwardPE":8.5,"priceToBook":1.45,"priceToSales":0.79,"enterpriseToRevenue":1.45,"enterpriseToEbitda":8.1,"pegRatio":36.68,"ebitda":2018000000,"ebitdaMargin":17.9,"freeCashflow":2432875008,"operatingCashflow":845000000,"totalDebt":9779999744,"debtToEquity":160.3,"currentRatio":2.31,"returnOnAssets":2.8,"returnOnEquity":-13.7,"analystRating":"2.7 - Hold","recommendationKey":"hold","numberOfAnalysts":13,"targetMeanPrice":22.12,"targetHighPrice":40,"targetLowPrice":17,"dividendRate":0.36,"payoutRatio":3.08,"fiveYearAvgDividendYield":2.44,"exDividendDate":1772150400,"insiderHeldPercent":0.3,"institutionHeldPercent":110.3,"sharesOutstanding":516252514,"floatShares":512185130,"sharesShort":37706710,"shortRatio":3.44,"shortPercentOfFloat":7.3,"epsTrailing":-1.75,"epsForward":2.04,"revenuePerShare":21.92,"bookValue":11.92,"officers":[{"age":48,"name":"Mr. Andrew P. Hider","title":"CEO, President, Interim Group President of Medical Products & Therapies and Director"},{"age":65,"name":"Mr. David S. Rosenbloom","title":"Executive VP & General Counsel"},{"age":48,"name":"Mr. Reazur  Rasul","title":"Executive VP & Group President of Healthcare Systems and Technologies"},{"age":54,"name":"Mr. Joel T. Grade","title":"Advisor"},{"age":null,"name":"Ms. Maria  Soriano","title":"Group President of Infusion Therapies, Technologies & Pharmaceuticals"},{"age":52,"name":"Ms. Anita A. Zielinski","title":"Interim CFO, Senior VP, Chief Accounting Officer & Controller"},{"age":55,"name":"Mr. Charles Rusty Patel","title":"Senior VP & Chief Information Officer"},{"age":null,"name":"Mr. Kevin  Moran","title":"Vice President & Head of Investor Relations"}],"industry":"Medical Instruments & Supplies","irWebsite":"http://investor.baxter.com/phoenix.zhtml?c=86121&p=irol-stockQuoteChart","website":"https://www.baxter.com","phone":"224 948 2000"}}